Bio-Rad Laboratories Class A
502 hedge funds and large institutions have $9.2B invested in Bio-Rad Laboratories Class A in 2023 Q1 according to their latest regulatory filings, with 78 funds opening new positions, 196 increasing their positions, 160 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
502
Holders Change
+33
Holders Change %
+7.04%
% of All Funds
8.03%
Holding in Top 10
13
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+85.71%
% of All Funds
0.21%
New
78
Increased
196
Reduced
160
Closed
39
Calls
$40.2M
Puts
$57.4M
Net Calls
-$17.2M
Net Calls Change
+$7.48M
Top Buyers
| 1 |
Los Angeles Capital Management
Los Angeles,
California
|
+$88.5M |
| 2 |
EC
Eminence Capital
New York
|
+$80.5M |
| 3 |
Millennium Management
New York
|
+$68.1M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$61.9M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$55M |
Top Sellers
| 1 |
Amundi
Paris,
France
|
-$70.8M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$47.2M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$40.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.7M |
| 5 |
A
AustralianSuper
Melbourne,
Australia
|
-$32.9M |
